Evidence map›Paper›PMID 42346609›Full record

ArticleJournal of personalized medicine2026

Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer Treatment.

Vered Bar, Adi Zundelevich, Nancy Gavert, Sara Aharon, Bassima Ibrahim, Anna Kosenko, Guy Neev, Ronen Viner, Ravid Straussman, Raanan Berger and 1 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vered BarCuresponse, Ltd., Rehovot 7670101, Israel.
Adi ZundelevichCuresponse, Ltd., Rehovot 7670101, Israel.
Nancy GavertDepartment of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0003-1639-4684
Sara AharonCuresponse, Ltd., Rehovot 7670101, Israel.
Bassima IbrahimCuresponse, Ltd., Rehovot 7670101, Israel.
Anna KosenkoCuresponse, Ltd., Rehovot 7670101, Israel.
Guy NeevCuresponse, Ltd., Rehovot 7670101, Israel.
Ronen VinerCuresponse, Ltd., Rehovot 7670101, Israel.
Ravid StraussmanDepartment of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 7610001, Israel.
Raanan BergerCuresponse, Ltd., Rehovot 7670101, Israel.
Seth J SalpeterCuresponse, Ltd., Rehovot 7670101, Israel.

Funding

CSRD VA 1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

functional cancer diagnosticin vitro diagnosticmolecular pathologypersonalized medicine

Identifiers

PMID42346609
PMCPMC13301710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.